• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素非依赖性前列腺癌细胞中雄激素受体依赖性前列腺特异性抗原(PSA)的表达并不涉及雄激素受体对PSA基因座的占据。

Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.

作者信息

Jia Li, Coetzee Gerhard A

机构信息

Department of Urology and Preventive Medicine, Norris Cancer Center, USC Keck School of Medicine, Los Angeles, California 90089, USA.

出版信息

Cancer Res. 2005 Sep 1;65(17):8003-8. doi: 10.1158/0008-5472.CAN-04-3679.

DOI:10.1158/0008-5472.CAN-04-3679
PMID:16140973
Abstract

It is widely suspected that androgen-independent prostate cancer growth depends on androgen receptor signaling via ill-defined mechanisms. Prostate-specific antigen (PSA) expression is often used to measure androgen receptor activity in cells and prostate cancer progression in patients. In the present study, we have compared androgen receptor activity using PSA and human male germ cell-associated kinase (hMAK), as read-outs in androgen-dependent LNCaP and androgen-independent C4-2B cells. As expected, very little PSA and hMAK expression were detected in LNCaP cells in the absence of androgens, whereas substantial expression of PSA was observed only in C4-2B cells under the same conditions. The addition of dihydrotestosterone to the culture medium increased the expression of both genes in both cell types. Comprehensive chromatin immunoprecipitation analysis of the entire PSA locus and an androgen-response element in hMAK unexpectedly revealed that androgen receptor was not occupying any site in the absence of dihydrotestosterone in either cell type. In line with the expression data, and in the absence of dihydrotestosterone, histone acetylation and RNA polymerase II occupancy was substantial at the PSA locus in C4-2B but not in LNCaP cells. In the presence of dihydrotestosterone, androgen receptor was found to occupy mainly the enhancer region of PSA in both cell types, accompanied with increases in histone acetylation and RNA polymerase II occupancy. Although the androgen receptor was not directly involved in the androgen-independent expression of PSA in C4-2B cells, small interfering RNA knock-down of androgen receptor significantly reduced PSA expression in both the presence and absence of dihydrotestosterone. In contrast, hMAK expression was decreased only in the presence of dihydrotestosterone after androgen receptor knock-down. We conclude that androgen-independent expression of PSA in C4-2B cells does not rely on the direct occupancy of the androgen receptor at the PSA locus, but is nevertheless affected indirectly via unknown androgen receptor-dependent mechanism(s) that influence the expression from some but not all androgen receptor target genes.

摘要

人们普遍怀疑雄激素非依赖性前列腺癌的生长依赖于雄激素受体信号传导,但其机制尚不明确。前列腺特异性抗原(PSA)的表达常被用于衡量细胞中的雄激素受体活性以及患者前列腺癌的进展情况。在本研究中,我们比较了使用PSA和人类男性生殖细胞相关激酶(hMAK)作为雄激素依赖性LNCaP细胞和雄激素非依赖性C4-2B细胞中雄激素受体活性的读出指标。不出所料,在无雄激素的情况下,LNCaP细胞中几乎检测不到PSA和hMAK表达,而在相同条件下,仅在C4-2B细胞中观察到大量的PSA表达。向培养基中添加二氢睾酮可增加两种细胞类型中这两个基因的表达。对整个PSA基因座和hMAK中的一个雄激素反应元件进行全面的染色质免疫沉淀分析,意外地发现,在无二氢睾酮的情况下,两种细胞类型中的雄激素受体均未占据任何位点。与表达数据一致,在无二氢睾酮的情况下,C4-2B细胞中PSA基因座处的组蛋白乙酰化和RNA聚合酶II占据情况显著,但LNCaP细胞中并非如此。在有二氢睾酮存在的情况下,发现雄激素受体主要占据两种细胞类型中PSA的增强子区域,同时伴随着组蛋白乙酰化和RNA聚合酶II占据情况的增加。尽管雄激素受体不直接参与C4-2B细胞中PSA的雄激素非依赖性表达,但雄激素受体的小干扰RNA敲低在有和无二氢睾酮的情况下均显著降低了PSA表达。相反,雄激素受体敲低后,仅在有二氢睾酮存在时hMAK表达降低。我们得出结论,C4-2B细胞中PSA的雄激素非依赖性表达不依赖于雄激素受体在PSA基因座上的直接占据,但仍然通过未知的雄激素受体依赖性机制受到间接影响,这些机制影响部分而非全部雄激素受体靶基因的表达。

相似文献

1
Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.雄激素非依赖性前列腺癌细胞中雄激素受体依赖性前列腺特异性抗原(PSA)的表达并不涉及雄激素受体对PSA基因座的占据。
Cancer Res. 2005 Sep 1;65(17):8003-8. doi: 10.1158/0008-5472.CAN-04-3679.
2
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.前列腺特异性抗原基因座处的雄激素受体活性:甾体和非甾体机制。
Mol Cancer Res. 2003 Mar;1(5):385-92.
3
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.在长期用白细胞介素-6处理的前列腺癌细胞中,p300调节前列腺特异性抗原的雄激素受体非依赖性表达。
Cancer Res. 2005 Jul 1;65(13):5965-73. doi: 10.1158/0008-5472.CAN-04-2837.
4
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.前列腺特异性抗原(PSA)启动子驱动的碘化钠同向转运体在前列腺癌细胞系中的雄激素诱导表达。
Cancer Res. 1999 May 1;59(9):2136-41.
5
Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.雄激素不敏感型前列腺癌亚培养细胞系中前列腺特异性抗原基因的表达
Anticancer Res. 2008 Jul-Aug;28(4A):1969-76.
6
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.分化剂丁酸盐在人前列腺癌细胞中对雄激素受体的非配体依赖性激活。
Cancer Res. 2000 Oct 15;60(20):5825-31.
7
Androgen receptor-mediated repression of novel target genes.雄激素受体介导的新型靶基因抑制作用。
Prostate. 2007 Sep 15;67(13):1371-83. doi: 10.1002/pros.20623.
8
Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.在人前列腺癌细胞中,缺氧可协同增强雄激素依赖的前列腺特异性抗原基因表达。
Mol Cancer Res. 2007 Apr;5(4):383-91. doi: 10.1158/1541-7786.MCR-06-0226.
9
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.蛙皮素在前列腺癌细胞中激活p300组蛋白乙酰转移酶活性并使雄激素受体乙酰化。
Oncogene. 2006 Mar 30;25(14):2011-21. doi: 10.1038/sj.onc.1209231.
10
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.转化生长因子-β信号传导和雄激素受体状态决定了人类前列腺癌细胞中的凋亡串扰。
Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

引用本文的文献

1
The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer.进化博弈论对理解和治疗癌症的贡献。
Dyn Games Appl. 2022;12(2):313-342. doi: 10.1007/s13235-021-00397-w. Epub 2021 Aug 30.
2
Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer.自噬为前列腺癌骨转移提供了一个概念性的治疗框架。
Cell Death Dis. 2021 Oct 5;12(10):909. doi: 10.1038/s41419-021-04181-x.
3
Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling.
增殖细胞核抗原直接与雄激素受体相互作用,增强雄激素受体介导的信号转导。
Int J Oncol. 2021 Jul;59(1). doi: 10.3892/ijo.2021.5221. Epub 2021 May 13.
4
SWATH-MS Based Proteomic Profiling of Prostate Cancer Cells Reveals Adaptive Molecular Mechanisms in Response to Anti-Androgen Therapy.基于SWATH-MS的前列腺癌细胞蛋白质组学分析揭示了抗雄激素治疗的适应性分子机制。
Cancers (Basel). 2021 Feb 9;13(4):715. doi: 10.3390/cancers13040715.
5
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells.癌-睾丸抗原、精液凝胶蛋白1和2对人肺腺癌细胞表现出不同的抗增殖作用。
Cell Death Discov. 2020 Oct 22;6:108. doi: 10.1038/s41420-020-00336-5. eCollection 2020.
6
Histoprotective Effect of Essential Oil from in Testosterone-Induced Benign Prostatic Hyperplasia Rat.[具体植物名称]精油对睾酮诱导的良性前列腺增生大鼠的组织保护作用
Adv Urol. 2019 Sep 25;2019:3031609. doi: 10.1155/2019/3031609. eCollection 2019.
7
Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility.前列腺特异性抗原(PSA/KLK3)的突变与男性不育有关。
Sci Rep. 2017 Sep 11;7(1):11225. doi: 10.1038/s41598-017-10866-1.
8
Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.诱饵分子对雄激素受体的抑制作用可延缓前列腺癌进展至去势复发阶段。
PLoS One. 2017 Mar 17;12(3):e0174134. doi: 10.1371/journal.pone.0174134. eCollection 2017.
9
4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.4C-seq揭示了位于8q24前列腺癌风险位点的一个功能性增强子的长程相互作用。
Sci Rep. 2016 Mar 3;6:22462. doi: 10.1038/srep22462.
10
Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.靶向BikDD表达可杀死雄激素依赖性和去势抵抗性前列腺癌细胞。
Mol Cancer Ther. 2014 Jul;13(7):1813-25. doi: 10.1158/1535-7163.MCT-13-1004. Epub 2014 Apr 30.